Atovaquone and proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in zambia
- 1 May 1999
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (5) , 841-852
- https://doi.org/10.1016/s0149-2918(99)80006-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Atovaquone and proguanil for Plasmodium falciparum malariaThe Lancet, 1996
- Clinical Studies of Atovaquone, Alone or in Combination with other Antimalarial Drugs, for Treatment of Acute Uncomplicated Malaria in ThailandThe American Journal of Tropical Medicine and Hygiene, 1996
- Cardiac complications of halofantrine: a prospective study of 20 patientsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Interactions of Atovaquone with Other Antimalarial Drugs against Plasmodium falciparum in VitroExperimental Parasitology, 1995
- Cardiac effects of antimalarial treatment with halofantrineThe Lancet, 1993
- Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)Biochemical Pharmacology, 1992
- Neuropsychiatric Side Effects after the use of MefloquineThe American Journal of Tropical Medicine and Hygiene, 1991
- Fatal Hepatic Necrosis Due to Pyrimethamine-Sulfadoxine (Fansidar)Annals of Internal Medicine, 1987
- Severe Cutaneous Reactions among American Travelers Using Pyrimethamine-Sulfadoxine (Fansidar®) for Malaria ProphylaxisThe American Journal of Tropical Medicine and Hygiene, 1986
- STEVENS-JOHNSON SYNDROME AFTER MASS PROPHYLAXIS WITH SULFADOXINE FOR CHOLERA IN MOZAMBIQUEThe Lancet, 1985